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Conclusion: Hospital-Acquired Infections are relatively
low in the studied hospital, when compared to similar
Colombian and international institutions. The most frequent
nosocomial infection was that of the surgical site, with the
most common microorganism being E. coli, which showed a
medium-to-low antibiotic resistance to ﬁrst- and second-line
antibiotics. In the studied hospital, intensive educational
programs have showed a marked success in diminishing
Hospital-Acquired Infection rates.
doi:10.1016/j.ijid.2010.02.2066
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‘‘Non Traditional’’ Extended Spectrum Beta-lactamase-
producing Isolates at a Community Hospital
R. Nog ∗, K. Singaravelu, P. Dhaubhadel, A. Guddati, S.
Upadhyay, S. Mannheimer, C. Badshah, V. Sivapalan
Columbia University College Of Physicians and Surgeons
afﬁliation at Harlem Hospital Center, New York, NY, USA
Background: Extended spectrum $-lactamase (ESBL)-
producing gram-negative bacteria (GNB) represent the most
common multidrug-resistant organism infections worldwide,
with limited treatment options and frequent adverse out-
comes. Two decades since their initial recognition, ESBL
producing organisms continue to pose a challenge to infec-
tious disease and infection control practitioners. ESBL
activity is most frequently described in Klebsiella spp. and
Escherichia coli. The prevalence and mortality associated
with other gram-negative bacteria with ESBL activity has
not been documented as well.
Objective: To describe trends of ESBL activity in culture
isolates obtained at a community hospital in New York.
Trend: Traditional vs Non-Traditional ESBLs
Methods: A retrospective chart- review of inpatients
over a three-year period (1/1/06 to 12/31/08) was
conducted to identify cultures positive for GNB. ESBL
activity was deﬁned based on antibiogram resistance
to cephalosporins, monobactams and penicillin. Data on
demographics, imipenem/cilastatin (IMP) resistance and dis-
charge status was collected. E. coli and Klebsiella were
deﬁned as Traditional ESBL’s (T-ESBL) and other GNB (Pseu-
domanas, Serratia, Citrobacter, Proteus etc.) were grouped
as Non-Traditional ESBL (NT-ESBL). The mortality rate was
calculated by discharge status.s
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ESBLs Rate of Imipenem resistance and All Cause Mor-
ality
Results: Among a total of 3032 isolates evaluated dur-
ng study period, 19.1% (n = 579) were deﬁned as ESBL. Of
hese 579 isolates, 23.3% (n = 135) were T-ESBL and 76.7%
n = 444) were NT-ESBL. The proportion of NT-ESBL remained
onsistently high during this period (68 to 83%). Among ESBL
solates, 211 (36.44%) exhibited IMP resistance of which
0 (33.18%) were T-ESBL and 141 (66.82%) were NT-ESBL.
his greater proportion of IMP resistant NT-ESBL organisms
as consistently represented (rates of 72.58%, 52.86% and
4.68% in 2006, 07 and 08 respectively). Of the 269 unique
atients with ESBL infection identiﬁed during the study
5.65% (n = 69) expired. Two thirds of these patients (78.03%,
= 54) had NT-ESBL organisms.
Conclusion: The majority of the ESBL-producing iso-
ates examined over a three year period at our institution,
ere non-traditional (other than E.coli and Klebsiella spp)
SBL-producing organisms. These were more likely to be
mipenem-resistant and associated with fatal outcomes.
herefore, monitoring ESBL activity in Klebsiella spp. and
scherichia coli isolates alone may underestimate the real
xtent of problem, precluding timely initiation of appropri-
te antibiotics and infection control practices.
oi:10.1016/j.ijid.2010.02.2067
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entilator-associated pneumonia in HIV-infected ICU
atients
. Gino ∗, H. Bagnulo
Hospital Maciel, Montevideo, Uruguay
Background: Ventilator-associated pneumonia (VAP) is
he main complication of mechanical ventilation (MV), it
ccurs in 27% of the mechanical ventilated (MV) patients in
ur Unit. VAP in HIV infected patients has the same incidente
nd etiology than in HIV-non infected The objective of the
tudy is to determine the incidence, etiology and outcome
f VAP in HIV infected patients admitted in an ICU.
Methods: We performed a retrospective analisis of all
he HIV infected patients admitted to ICU of Hospital Maciel
rom June 1990 to December 2008 who were on MV. Cate-
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orical variables were expressed in median and interquartile
ange. Chi square was used when applied. P value <0.05 was
onsidered signiﬁcative.
Results: 351 HIV patients were assisted during the period.
edian age was 32 YO (27—39). 73.5% male and 26.5%
emale. Median SAPS II 35 (29—43). 186 (54%) were on MV.
ength of stay was 6 days (3—11). 162 patients (46.2%)
ied. Considering patients on MV, SAPS II was 41 (34—51),
ength of stay in ICU was 6 days (2—10) and 143 died
76.9%) VAP ocurred as a complication in 43 (23%) patients
n MV, median SAPS II was 36 (31—42), length of stay 12
ays (9—17), 39/43 died (90.7%) 35 (89.7%) of whom died
n septic shock Etiology: Acinetobacter 17, Pseudomona
eruginosa 14, Methicillin-sensitve Staphylococcus aureus 4,
ethicillin-resistant Staphylococcus aureus 4 and Klebsiella
p 4. 143 patients (77%) on MV did not develop VAP, SAPS
I was 43 (36—54), length of stay in ICU 4 days (2—8), 104
72.7%) died. Patients on MV who developed VAP were less
ll at admission (SAPS II 36 vs 43 p < 0.001) length of stay was
onger (12 vs 4 p < 0.001 and mortality was higher (39/43 vs
04/143 OR 3.66 [CI 1.15—12.9]).
Conclusion: Although HIV-infected patients VAP incidence
nd etiology is similar to that of the HIV-non infected
atients, its overwhelming evolution to multiorgan failure
ndmuch highermortality almost always represents the ﬁnal
vent in the clinical evolution of this group of ICU patients.
oi:10.1016/j.ijid.2010.02.2068
6.030
mplementation of a central line bundle to reduce central
ine associated bacteremia at the intensive care unit
. Alvarez1, J. Pisapia1, C. Rosello1, M. Lira1, M. Curone1,
. Vidiella2,∗
Maternidad Suizo Argentina, Buenos Aires, Argentina
Maternidad Suizo Argentina y Sanatorio Agote, Buenos
ires, Argentina
Background: Central line associated bacteremia (CLAB) is
ssociated with an increased length of stay of up to 6 days
t the intensive care unit (ICU), with an attributable mor-
ality of 35% approximately. The reduction in the incidence
f Methicillin-resistant staphylococcus aureus (MRSA) cen-
ral line associated bloodstream Infections continues being
challenge according to the last tendencies published by the
DC in the (ICU) of the United States. S. aureus is the most
recuent pathogen causing blood stream infections in Latin
merica (SENTRY 1996-2006). The prevalence of nosocomial
. aureus oxacillin resistant is 46% in Argentina. The purpose
f this study was to decrease CLAB at the ICU, particulary
RSA (most prevalent pathogen of CLAB in our institution).
Methods: Data was collected from September 1, 2007 to
uly 1, 2009, on all ICU patients who had central venous
atheter placed at the Clínica y Maternidad Suizo Argentina.
fter one year of baseline data collection the infection con-
rol team implemented a set of measures for the insertion
f CVC (bundle): antiseptic handwashing, maximal barrier
recaution, skin preparation with chlorhexidine 2% instead
f iodopovidone solution, use of gown mask and cap for
he assistant and avoidance of femoral lines. The staff
f physician and nurses was educated on bloodstream-
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nfection-control practices before the new elements were
dded to the protocol. A check list form was ﬁlled out by
n ICU nurse manager after each central line placement.
he NHSN criteria for CLAB were met. The data were col-
ected by an infection control nurse. The rates of CLAB were
alculated with Excel and Epi 5 Control Argentina program.
Results: During the pre-intervention period the rate of
LAB was 9,47 ‰ (1900 CVC lineday) and decreased to 3,62
post-intervention (1934 CVC line-day). The rate of gram
ositive CLAB also decreased from 6,84 ‰ (IC. 0.31%-0.15%)
o 1,55 ‰ (IC. 0,02%—0,33%). P: < 0,022.This decreasing ten-
ency was also observed in relation to the MRSA(5 ‰ versus
,09 ‰).
Conclusion: The use of central line bundle and to mon-
tor its adherence with a central line insertion check list,
igniﬁcantly reduced the rate of CLAB.
oi:10.1016/j.ijid.2010.02.2069
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henotipic and molecular characteristics of Clostridium
ifﬁcile infections in a tertiary-care center
. Mendoza1,∗, A. Camacho2, J.O. Herrera2, J.E. Diaz2,
.D.M. Aldrete2, A.L. Martinez2, A. Hernandez2, M.
obadilla2, A. Ponce de Leon2, J. Sifuentes2
Instituto Nacional de Ciencias Médicas y Nutrición Salvador
ubirán, Mexico City, Mexico, Mexico
Instituto Nacional de Ciencias Méidcas y Nutrición Salvador
ubirán, Mexico City, Mexico, Mexico
Background: An increased number of cases of C. difﬁcile
ssociated disease (CDAD) has been observed, associated
ith the emergence of a particular strain, NAP1/BI/027. The
bjective of this prospective study was to characterise C.
ifﬁcile isolates in a referral hospital.
Methods: From 6/1/2008 to 9/30/2009 all stool samples
ent to the clinical microbiology laboratory for C. difﬁcile
oxin A/B detection were processed by a commercial EIA and
ulture. A further RT-PCR for detection of TcdC was done
n all positive samples for either toxin or culture; in each
solate multiplex-PCR was performed to detect TcdA/TcdB
nd CdtA/CdtB genes, and all isolates were ribotyped. Clin-
cal data was recorded from patients with a positive result.
DAD was diagnosed when the microbiology data supported
he clinical ﬁndings.
Results: A total of 1093 samples were screened for toxin
/B and culture; 6.2% were positive by toxin A/B detec-
ion (68/1093), 8.32% (91/1093) by culture, and 10.52%
115/1093) by any of them. Out of the 115 cases, 13 were
xcluded. From the 102 remaining patients, only 85 (83%)
ad CDAD; 25 (29.5%) had severe CDAD; 55 received oral
etronidazole: 89% cured, 7.3% relapsed, and 11% failed.
rom 64 isolates from CDAD patients: 45.3% had a negative
oxin A/B, 89% a positive TcdA/TcdB, and 87.5% had a posi-
ive TcdC; 35.7% revealed the characteristic 18 pb deletion
n TcdC, and 10 patients had severe disease (40% vs 16%,
< 0.02). From 55 ribotyped isolates, 49 (89%) were groupedn 11 clusters, none similar to the 027 ribotype. From 20
evere CDAD isolates analysed, 3 showed the 18 bp deletion,
ositive CdtA/CdtB genes and quinolone resistance.
